Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

One More Reason That Lilly Must Do A Deal, Fast
Pharmalot
Wednesday, October 20, 2010 - 9:32am
tags:
Eli Lilly, M&A, Amylin, Bydureon, diabetes, Alkermes
Magic Number: Tylenol Recall Cost J&J $665M in Lost Sales
BNET Pharma
Wednesday, October 20, 2010 - 9:30am
tags:
Tylenol, recalls, JNJ, earnings
Abbott third-quarter net income falls 40%
Marketwatch
Wednesday, October 20, 2010 - 9:28am
tags:
earnings, Abbott Laboratories
Genzyme 3Q: Not Your Run-of-the-Mill Earnings Report
WSJ Online
Wednesday, October 20, 2010 - 9:26am
tags:
earnings, Genzyme
Pfizer buys 40% stake in Teuto S.A. for $240 mln
Marketwatch
Wednesday, October 20, 2010 - 9:26am
tags:
M&A, Teuto S.A., Brazil, Pfizer
Merck's Vioxx Fund Must Pay Lawyers Who Led Case $315 Million, Judge Rules
Bloomberg
Tuesday, October 19, 2010 - 10:30pm
tags:
Merck, settlements, Vioxx
Alkermes' Drug Approval On Tap
Investors.com
Tuesday, October 19, 2010 - 10:28pm
tags:
Alkermes, FDA, Bydureon, diabetes, Eli Lilly, Amylin, Byetta, Vivitrol, alcoholism
Lilly, Novo tops among diabetes doctors
Fierce Pharma
Tuesday, October 19, 2010 - 6:48pm
tags:
Eli Lilly, Novo Nordisk, diabetes, physicians
Boehringer Wins FDA Approval for First Warfarin Rival
Bloomberg
Tuesday, October 19, 2010 - 6:46pm
tags:
FDA, Boehringer Ingelheim, Warfarin, Bayer, Pradaxa, blood thinners
Gilead Earnings Beat Street
TheStreet.com
Tuesday, October 19, 2010 - 4:23pm
tags:
Gilead Sciences, earnings
Genzyme Corp: Earnings Preview
Yahoo/Zacks.com
Tuesday, October 19, 2010 - 4:20pm
tags:
earnings, Genzyme
Sanofi-Aventis Wins $442 Million Award Against Apotex Over Plavix Patent
Bloomberg
Tuesday, October 19, 2010 - 4:19pm
tags:
Apotex, Sanofi, lawsuits, patents, Plavix
The Biotech Advantage: Why women start biotech firms at higher rates than they start other kinds of high-tech firms
Slate
Tuesday, October 19, 2010 - 11:46am
tags:
biotech, women, start-ups
Transcept readies second attempt at sleep drug approval
Fierce Biotech
Tuesday, October 19, 2010 - 11:42am
tags:
Transcept, insomnia, Intermezzo
Doc-payment database details industry ties
Fierce Pharma
Tuesday, October 19, 2010 - 11:39am
tags:
physician payments, GSK, AstraZeneca, Eli Lilly, Merck, Pfizer, JNJ, Cephalon
J&J Ups Full-Year Guidance
TheStreet.com
Tuesday, October 19, 2010 - 11:37am
tags:
JNJ, guidance
Cell Therapeutics: Empty Promises
TheStreet.com
Tuesday, October 19, 2010 - 11:36am
tags:
Cell Therapeutics, lymphoma, pixantrone
Forest Laboratories 2Q profit grows 53 percent
Yahoo/AP
Tuesday, October 19, 2010 - 11:23am
tags:
earnings, Forest Labs
ShangPharma's IPO: Priced About Right for the Short Term
Seeking Alpha
Tuesday, October 19, 2010 - 11:09am
tags:
ShangPharma, IPOs, China
Biosimilar threat tarnishes Novo's star status
Reuters
Tuesday, October 19, 2010 - 11:07am
tags:
Novo Nordisk, insulin, biosimilars, Biocon, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.